Paradox Immunotherapeutics

Paradox Immunotherapeutics is a biotechnology company developing first-in-class monoclonal antibody (mAb) treatments for protein misfolding diseases. Paradox designs and develops specialized antibodies that selectively target and remove only the problematic or misfolded proteins, leaving the healthy proteins in your body completely unaffected.